GlassScriptPhysician profile
Ryan Britton Nance
NPI 1063808988
$3,659.00
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34.59 · 2020: $3,079 · 2021: $98.56 · 2022: $137 · 2023: $248 · 2024: $62.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $310.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $310.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,046.83 | 2020 | |
| Abbvie INC. | $161.14 | 2019-2023 | |
| Astellas Pharma US INC | $109.78 | 2023 | Veozah, Myrbetriq |
| Organon LLC | $73.60 | 2021-2024 | Nexplanon |
| Myovant Sciences INC. | $37.02 | 2021-2022 | |
| Covidien LP | $31.93 | 2020 | |
| Coopersurgical, INC. | $29.34 | 2023 | Summit Doppler |
| Janssen Pharmaceuticals, INC | $26.08 | 2022 | |
| Medtronic, INC. | $18.45 | 2022 | |
| Davol INC. | $17.51 | 2024 | Arista Ah Flexitip |
| Daiichi Sankyo INC. | $16.74 | 2023 | Injectafer |
| Therapeuticsmd, INC. | $16.67 | 2021 | |
| Novo Nordisk INC | $16.23 | 2023 | Wegovy |
| Ethicon US, LLC | $15.77 | 2022 | |
| Avion Pharmaceuticals | $15.75 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $13.49 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.67 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Nance listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.